Google
×
The Investor Relations website contains information about GlycoMimetics, Inc.'s business for stockholders, potential investors, and financial analysts.
GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024. February 26, 2024. GlycoMimetics to Participate in Upcoming ...
People also ask
Find annual and quearterly earnings data for GlycoMimetics, Inc. Common Stock (GLYC) including earnings per share, earnings forecasts at Nasdaq.com.
Get the latest GlycoMimetics, Inc. (GLYC) stock news and headlines to help you in your trading and investing decisions.
Mar 1, 2024 · GlycoMimetics (GLYC) has issued an announcement. GlycoMimetics, Inc. has prepared a slide presentation for upcoming investor meetings, ...
Retail investors in GlycoMimetics, Inc. (NASDAQ:GLYC) are its biggest bettors, and their bets paid off as stock gained 23% last week. Key Insights Significant ...
(GLYC) CEO Harout Semerjian on Q4 2021 Results - Earnings Call Transcript · SA TranscriptsThu, Mar. 03, 2022. GlycoMimetics (GLYC) Investor Presentation - ...
Missing: relations | Show results with:relations
7 days ago · Investors are always looking for stocks that are poised to beat at earnings season and GlycoMimetics, Inc. GLYC may be one such company.
Investor Relations URL, http://ir.glycomimetics.com/. HQ State/Province, Maryland. Sector, Healthcare. Industry, Biotechnology. Equity Style, Small Cap/Value.
GlycoMimetics, Inc. (US:GLYC) has 81 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).